Recent abolon transactions

Abolon advises L&W Intensivpflege on its sale to Linimed

Abolon was the exclusive advisor to the shareholders on the sale of L&W Intensivpflege Group to Linimed, one of the leading German providers in the field of outpatient intensive care. The transaction was completed at the end of February 2022. It was agreed not to disclose the transaction value. L&W Intensivpflege (consisting of Advivo – ambulante Beatmung GmbH, L&W Intensivpflegedienst GmbH und L&W Intensivpflege GmbH) is a specialized care service for intensive care and home ventilation in out-patient living groups (`Wohngruppen`) and 24-hour care at home in the greater Munich area and Lower Bavaria.

Read more

Healthcare insights

How will new landmark legislation affect Germany’s private hospital groups

The new Hospital Structure Act could force small, low quality public sector hospitals to the wall. But it could also cap growth for big private operators. We examine likely scenarios.

Read more

Healthcare deal of the month

December 2015: Etac acquires Convaid

The Deal: In December 2015, Etac, a Sweden-based developer and manufacturer of mobility solutions and rehab products, acquired Convaid Products

Read more

WELCOME TO ABOLON

Abolon is a strategy consulting and corporate finance company with an exclusive focus on the healthcare sector.

We pride ourselves on our specialist insights into the various segments of the healthcare markets in Europe and beyond.

Our global network in the healthcare sector provides us with unmatched dealflow of large and mid-sized healthcare opportunities.

Facts & figures

  • Healthcare forms an enormous ...
  • Stable healthcare sector attracts ...
  • The global pharmaceutical market ...
  • The healthcare sector offers ...
  • Abolon has advised on ...
  • Healthcare forms an enormous part of developed country's economy, contributing over 10 percent of gross domestic product (GDP).
  • Stable healthcare sector attracts record private equity investments.
  • The global pharmaceutical market is expected to grow from 995 $bn in 2011 to 1160 $bn in 2016
  • The healthcare sector offers numerous opportunities at low risk
  • Abolon has advised on 4 successful healthcare transactions in the last 18 months.